These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7536627)

  • 1. MHC class I-peptide interactions and TCR recognition.
    Young AC; Zhang W; Sacchettini JC; Nathenson SG
    Cancer Surv; 1995; 22():17-36. PubMed ID: 7536627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analysis of MHC class I molecules with bound peptide antigens.
    Wilson IA; Fremont DH
    Semin Immunol; 1993 Apr; 5(2):75-80. PubMed ID: 8504218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
    Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
    Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
    Smith KD; Lutz CT
    J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide binding by class I and class II MHC molecules.
    Batalia MA; Collins EJ
    Biopolymers; 1997; 43(4):281-302. PubMed ID: 9316393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class I MHC-peptide interaction: structural and functional aspects.
    Ruppert J; Kubo RT; Sidney J; Grey HM; Sette A
    Behring Inst Mitt; 1994 Jul; (94):48-60. PubMed ID: 7998914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural principles that govern the peptide-binding motifs of class I MHC molecules.
    Zhang C; Anderson A; DeLisi C
    J Mol Biol; 1998 Sep; 281(5):929-47. PubMed ID: 9719645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional structures of MHC class I-peptide complexes: implications for peptide recognition.
    Persson K; Schneider G
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):135-42. PubMed ID: 10912617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune recognition of viral antigens.
    Wilson IA; Stanfield RL; Jewell DA; Ghiara JB; Fremont DH; Stura EA
    Infect Agents Dis; 1994; 3(2-3):155-62. PubMed ID: 7812653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class I/peptide interactions: binding specificity and kinetics.
    Margulies DH; Corr M; Boyd LF; Khilko SN
    J Mol Recognit; 1993 Jun; 6(2):59-69. PubMed ID: 8305252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-induced conformational changes in class I molecules. Direct detection by flow cytometry.
    Rohren EM; McCormick DJ; Pease LR
    J Immunol; 1994 Jun; 152(11):5337-43. PubMed ID: 8189051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class I MHC-peptide interactions: structural requirements and functional implications.
    Grey HM; Ruppert J; Vitiello A; Sidney J; Kast WM; Kubo RT; Sette A
    Cancer Surv; 1995; 22():37-49. PubMed ID: 7536628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
    Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
    J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.
    Boehncke WH; Takeshita T; Pendleton CD; Houghten RA; Sadegh-Nasseri S; Racioppi L; Berzofsky JA; Germain RN
    J Immunol; 1993 Jan; 150(2):331-41. PubMed ID: 8093457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TcR recognition of the MHC-peptide dimer: structural properties of a ternary complex.
    Vasmatzis G; Cornette J; Sezerman U; DeLisi C
    J Mol Biol; 1996 Aug; 261(1):72-89. PubMed ID: 8760503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR.
    al-Ramadi BK; Jelonek MT; Boyd LF; Margulies DH; Bothwell AL
    J Immunol; 1995 Jul; 155(2):662-73. PubMed ID: 7541822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of peptide interaction with MHC creates TCR partial agonists.
    Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
    Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule.
    Tynan FE; Reid HH; Kjer-Nielsen L; Miles JJ; Wilce MC; Kostenko L; Borg NA; Williamson NA; Beddoe T; Purcell AW; Burrows SR; McCluskey J; Rossjohn J
    Nat Immunol; 2007 Mar; 8(3):268-76. PubMed ID: 17259989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of MHC class II and TCR binding residues in the type II collagen immunodominant determinant mediating collagen-induced arthritis.
    Rosloniec EF; Whittington KB; Brand DD; Myers LK; Stuart JM
    Cell Immunol; 1996 Aug; 172(1):21-8. PubMed ID: 8806802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.